These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25912617)

  • 41. Seasonal Influenza Prevention and Control Progress in Latin America and the Caribbean in the Context of the Global Influenza Strategy and the COVID-19 Pandemic.
    Vicari AS; Olson D; Vilajeliu A; Andrus JK; Ropero AM; Morens DM; Santos IJ; Azziz-Baumgartner E; Berman S
    Am J Trop Med Hyg; 2021 May; 105(1):93-101. PubMed ID: 33970888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Promote multidisciplinary integration, and strengthen capacities on prevention, control and pandemic preparedness of influenza].
    Feng LZ; Yang WZ
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(8):527-529. PubMed ID: 33663185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fourth meeting of the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network and first scientific conference on acute respiratory infections in the Eastern Mediterranean Region, 11-14 December, 2017, Amman, Jordan.
    Abubakar A; Barakat A; Ahmed A; El Kholy A; Alsawalh L; Al Ariqi L; Malik MR; Obtel M; Sahak M; Mrad P; Triki S; Al Awaidy S; Khan WM
    J Infect Public Health; 2019; 12(4):534-539. PubMed ID: 30733047
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canada's Pandemic Influenza Preparedness: Surveillance strategy.
    Henry B;
    Can Commun Dis Rep; 2018 Jan; 44(1):14-17. PubMed ID: 29770093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regional perspectives on influenza surveillance in Africa.
    Schoub BD; McAnerney JM; Besselaar TG
    Vaccine; 2002 May; 20 Suppl 2():S45-6. PubMed ID: 12110256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative.
    Díez-Domingo J; Torcel-Pagnon L; Carmona A; Launay O; Dos Santos G; Rizzo C; Haag M; Stuurman A; Nauta J; Vannacci A; de Lusignan S; Del Rey E; Levi M; Lina B; Bellino S; Nye S; Neels P; Nohynek H; Mahé C;
    Expert Rev Vaccines; 2022 Dec; 21(12):1701-1710. PubMed ID: 36261918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of monovalent influenza A-prime vaccine during 1957 influenza A-prime epidemic.
    MEIKLEJOHN G
    Am J Hyg; 1958 Mar; 67(2):237-49. PubMed ID: 13520709
    [No Abstract]   [Full Text] [Related]  

  • 48. CLINICAL trials of influenza vaccine: third progress report to the Medical Research Council by its Committee on Clinical Trials of Influenza Vaccine.
    Br Med J; 1957 Jul; 2(5035):1-7. PubMed ID: 13436844
    [No Abstract]   [Full Text] [Related]  

  • 49. [Epidemiological effectiveness of influenza vaccine].
    UNANOV SS
    Vopr Virusol; 1957; 2(2):86-91. PubMed ID: 13443242
    [No Abstract]   [Full Text] [Related]  

  • 50. Afriflu--international conference on influenza disease burden in Africa, 1-2 June 2010, Marrakech, Morocco.
    Steffen C; Diop OM; Gessner BD; Hacen MM; Hassar M; Katz MA; Miller MA; Paget WJ; Schoub BD; Vernet G; Ndumbe PM
    Vaccine; 2011 Jan; 29(3):363-9. PubMed ID: 21111779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Global Capacity for Influenza Surveillance.
    Polansky LS; Outin-Blenman S; Moen AC
    Emerg Infect Dis; 2016 Jun; 22(6):993-1001. PubMed ID: 27192395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of influenza vaccine on Asian influenza as reported in the international scientific medical press].
    MOUTOUSES K; PAPAPANAGIOTOU I
    Delt Hell Mikrobiol Hygieinol Hetair; 1958; 3(1):3-5. PubMed ID: 13532559
    [No Abstract]   [Full Text] [Related]  

  • 53. The influenza programme of WHO.
    PAYNE AM
    Bull World Health Organ; 1953; 8(5-6):755-74. PubMed ID: 13094504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Data, disease and diplomacy: GISAID's innovative contribution to global health.
    Elbe S; Buckland-Merrett G
    Glob Chall; 2017 Jan; 1(1):33-46. PubMed ID: 31565258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical evaluation of Asiatic influenza vaccine in Alberta.
    SMITH ES; CLEMENTS DI
    Can J Public Health; 1959 May; 50(5):179-82. PubMed ID: 13651999
    [No Abstract]   [Full Text] [Related]  

  • 56. Public health crisis preparedness and response in Korea.
    Lee HY; Oh MN; Park YS; Chu C; Son TJ
    Osong Public Health Res Perspect; 2013 Oct; 4(5):278-84. PubMed ID: 24298444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving surveillance of the impact of influenza and its prevention in Canada.
    Fedson DS
    Can J Infect Dis; 1993 Sep; 4(5):257-62. PubMed ID: 22346458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling.
    WHO Informal Network for Mathematical Modelling for Pandemic Influenza H1N1 2009 (Working Group on Data Needs)
    PLoS Curr; 2009 Dec; 1():RRN1135. PubMed ID: 20023711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The epidemiological nature of influenza and problems in its prevention].
    MIKHAILOVSKII VT; AGAFONOV VI
    Voen Med Zh; 1960 Mar; 3():77-82. PubMed ID: 13770511
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.